• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

AbbVie Completes Acquisition Of Cerevel; Reaffirms Full-year Adj. EPS Guidance Range

cafead

Administrator
Staff member
  • cafead   Aug 01, 2024 at 12:02: PM
via AbbVie (ABBV) has completed its acquisition of Cerevel Therapeutics. Cerevel is now part of AbbVie. The acquisition is expected to be accretive to adjusted earnings per share beginning in 2030.

article source
 

<